Roche Ocrevus

Beyond's analysis on Roche Ocrevus

• 2026-09-18 — CHMP recommendation expands Roche's Ocrevus market potential to pediatric patients with relapsing MS

Recent news mentioning Roche Ocrevus

• 2026-09-18 — CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis

Appears alongside

• CHMP

Browse the full archive →